• about
  • DC IMMUNOTHERAPY
    • THE PRINCIPLE
    • ABOUT MESOPHER
    • PUBLICATIONS
  • pipeline
    • PLEURAL MESOTHELIOMA
    • PERITONEAL MESOTHELIOMA
    • PANCREATIC CANCER
  • partners & investors
  • news
  • contact
  1. Home
  2. Coverage

Archives

Category Archive for: "Coverage"

Coverage of Amphera’s press release in Scrip and BioWorld

06 May 2019

Scrip’s John Davis wrote an article on Amphera:

https://scrip.pharmaintelligence.informa.com/SC124930/Amphera-Gears-Up-To-Evaluate-Dendritic-Cells-For-Pleural-Mesothelioma

Nuala Moran of BioWorld covered Amphera’s press release as well:

http://www.bioworld.com/content/amphera-taking-mesothelioma-dendritic-cell-vaccine

Read more »

Amphera video interview at BIO-Europe Spring 2019

06 May 2019

At BIO Europe Spring 2019 in Vienna, Rob Meijer was interviewed by Mike Ward – Informa on combination therapy of MesoPher and checkpoint inhibitors.

Read more »

National and regional newspapers in The Netherlands publish article on the MESOPEC study

01 Feb 2019

On January 25, 2018 National and regional newspapers in The Netherlands published an article on the MESOPEC study. Investigator dr. Eva Madsen and a patient are interviewed. MESOPEC is a phase II study with MesoPher in peritoneal mesothelioma.

The article (in Dutch) can be found on: https://www.ad.nl/wetenschap/veelbelovende-behandelmethode-tegen-asbestkanker~a900b9dc/

Read more »

Results Phase I/II study with MesoPher published in Clinical Cancer Research

12 Feb 2018

Amphera is happy to announce that the results of our phase I/II study with MesoPher in mesothelioma are published in the February 2018 issue of Clinical Cancer Research.

 

Read more »
  • disclaimer
  • privacy policy

© 2019 Scicomvisuals, all rights reserved.